Pharma stocks have bounced back from their prior selloff, but whether they will continue their upward trend under a Donald Trump administration remains unclear.
Pfizer will showcase third-quarter results, but investors will be more focused on the potential for its Inflectra drug, as well as its outlook on M&A.
Your retirement portfolio could get a salutary boost from biotech stocks along with ETFs in the sector that have generated large returns in 2016, producing double digit-gains.
Biotech and health care are two of the hottest sectors in which to invest. TheStreet compiled a list of the best-rated ETFs tracking the two sectors.